Other OTC Pharmaceuticals - Sweden

  • Sweden
  • In Sweden, the revenue in the Other OTC Pharmaceuticals market reached US$58.02m in 2024.
  • It is projected to experience an annual growth rate of 0.92% (CAGR 2024-2029).
  • When compared to the global market, the in the United States generates the highest revenue, amounting to US$7,171.00m in 2024.
  • Looking at the per capita figures, in 2024, each person in Sweden contributes US$5.44 in revenue.
  • The demand for natural and herbal OTC pharmaceuticals is on the rise in Sweden, driven by a growing preference for alternative medicine.

Key regions: United States, Brazil, Europe, Canada, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in Sweden is experiencing steady growth due to several factors. Customer preferences for self-medication, increasing health consciousness, and the availability of a wide range of OTC products are driving this growth. Additionally, local special circumstances and underlying macroeconomic factors are contributing to the development of the market.Customer preferences in Sweden are shifting towards self-medication, with consumers increasingly seeking OTC pharmaceuticals for common ailments. This trend is driven by the convenience and accessibility of OTC products, as they can be purchased without a prescription and are readily available in pharmacies, supermarkets, and online platforms. Furthermore, the growing health consciousness among consumers is also influencing their preference for OTC pharmaceuticals, as they seek to proactively manage their health and well-being.Trends in the market indicate a growing demand for OTC pharmaceuticals in Sweden. The market is witnessing an expansion in product offerings, with a wide range of OTC medications available for various conditions such as cough and cold, pain relief, digestive health, and allergies. This diversification of product offerings caters to the specific needs and preferences of consumers, further driving the growth of the market. Moreover, there is an increasing focus on natural and herbal remedies in the OTC segment, aligning with the growing trend of holistic and alternative medicine.Local special circumstances in Sweden contribute to the development of the Other OTC Pharmaceuticals market. The country has a well-established healthcare system, with a high level of trust in the quality and safety of OTC products. This trust, combined with the strong regulatory framework in place, ensures that consumers have access to reliable and effective OTC medications. Additionally, the Swedish population has a high disposable income, which enables them to afford OTC pharmaceuticals and fuels the demand for these products.Underlying macroeconomic factors also play a role in the growth of the Other OTC Pharmaceuticals market in Sweden. The country has a stable economy and a high standard of living, which translates into increased healthcare spending. As consumers prioritize their health and well-being, they are willing to invest in OTC pharmaceuticals to address minor health issues. Furthermore, the aging population in Sweden contributes to the market growth, as older individuals are more likely to require OTC medications for chronic conditions and age-related ailments.In conclusion, the Other OTC Pharmaceuticals market in Sweden is developing due to customer preferences for self-medication, increasing health consciousness, and the availability of a wide range of OTC products. Local special circumstances, such as the well-established healthcare system and high disposable income, further contribute to the growth of the market. Additionally, underlying macroeconomic factors, including a stable economy and an aging population, play a role in driving the demand for OTC pharmaceuticals in Sweden.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)